Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Borax, also known as sodium borate or sodium tetraborate, is a naturally occurring mineral compound typically found as a white crystalline powder, chemically identified as sodium tetraborate decahydrate (Na2B4O7·10H2O). While widely recognized for its industrial and household applications as a cleaner, laundry booster, insecticide, herbicide, and fungicide, borax also possesses historical and limited current medicinal uses. It functions as a mild antiseptic and astringent, and in pharmaceutical formulations, it is primarily utilized for its buffering properties to maintain pH and can offer mild antibiotic effects, particularly in ophthalmic solutions. Borax is not intended for internal consumption due to its moderate acute toxicity and potential for adverse health effects, including reproductive toxicity, with high or prolonged exposure. Its pharmaceutical applications are generally topical or as an excipient in combination products, often alongside boric acid.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Borax.